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a Distinct Retinopathy in Humans
Rosemary Burgess,1,8 Ian D. Millar,2 Bart P. Leroy,3,4 Jill E. Urquhart,1,8 Ian M. Fearon,2
Elfrida De Baere,4 Peter D. Brown,2 Anthony G. Robson,5,6 Genevieve A. Wright,5 Philippe Kestelyn,3
Graham E. Holder,5,6 Andrew R. Webster,5,6 Forbes D.C. Manson,1,7,8 and Graeme C.M. Black1,7,8,*
We describe a distinct retinal disorder, autosomal-recessive bestrophinopathy (ARB), that is consequent upon biallelicmutation in BEST1
and is associated with central visual loss, a characteristic retinopathy, an absent electro-oculogram light rise, and a reduced electroretino-
gram. Heterozygous mutations in BEST1 have previously been found to cause the two dominantly inherited disorders, Best macular
dystrophy and autosomal-dominant vitreoretinochoroidopathy. The transmembrane protein bestrophin-1, encoded by BEST1, is
located at the basolateral membrane of the retinal pigment epithelium in which it probably functions as a Cl channel. We sequenced
BEST1 in ﬁve families, identifying DNA variants in each of ten alleles. These encoded six different missense variants and one nonsense
variant. The alleles segregated appropriately for a recessive disorder in each family. No clinical or electrophysiological abnormalities were
identiﬁed in any heterozygotes. We conducted whole-cell patch-clamping of HEK293 cells transfected with bestrophin-1 to measure the
Cl current. Two ARB missense isoforms severely reduced channel activity. However, unlike two other alleles previously associated with
Best disease, cotransfection with wild-type bestrophin-1 did not impair the formation of active wild-type bestrophin-1 channels, con-
sistent with the recessive nature of the condition. We propose that ARB is the null phenotype of bestrophin-1 in humans.Introduction
The retinal pigment epithelium (RPE) is the cellular mono-
layer that interdigitates with the outer segments of photo-
receptors and is critical in homeostatic maintenance of the
outer retina.1 Furthermore, it is critical for the phagocyto-
sis of shed outer segments and is the site for the regenera-
tion of the chromophore 11-cis-retinal. Several inherited
retinal disorders are caused by mutations in RPE-expressed
genes including bothmacular and generalized photorecep-
tor dystrophies (RetNet). A classic example is Best disease
or vitelliform macular dystrophy (VMD, MIM 153700),
an autosomal-dominant disorder associated with a reduced
or absent electro-oculogram (EOG) and an accumulation of
yellowish material between the RPE and photoreceptors
in the macula. The condition leads to visual loss in late
adolescence or adulthood and is caused by mutations in
the BEST1 gene.2
The protein product of BEST1, bestrophin-1, is a 585
amino acid transmembrane protein located at or close to
the basolateral membrane of the RPE.3 Bestrophin-1 func-
tions as a Cl channel when expressed in HEK293 cells,4–6
and dominant mutations in putative transmembrane
domains of the murine ortholog alter anion permeability.6
Bestrophin-1 also alters the activity of L type Ca2þ chan-
nels when expressed in RPE-derived cells, suggesting that
it might also act to regulate entry of Ca2þ into RPE cells.7ThBestrophin-1 is thought to exist as an oligomer, and
when puriﬁed from porcine RPE, exists as a dimer.8
Over 100 different BEST1mutations have been described
in families affected by Best disease (University of Regens-
berg VMD2 database; e.g.,9–12). Almost all are missense
mutations located within the ﬁrst 310 residues, often
within or close to transmembrane domains. Some muta-
tions induce smaller whole-cell currents than wild-type
isoforms when expressed in HEK293 cells and act in a
dominant-negative manner because their coexpression
with wild-type bestrophin-1 severely reduces or abolishes
wild-type currents.4,13,14 Phenotypic variability among
patients carrying these mutations includes those with
adult-onset vitelliform dystrophy as well as atypical forms
of Best disease, including a single report by Schatz et al.
(2006) of a case associated with compound heterozygous
mutations.15 A second distinct dominant disorder, autoso-
mal-dominant vitreoretinochoroidopathy (ADVIRC, MIM
193220), has also been reported to be caused by mutation
of BEST1.16 These mutations disrupt BEST1 pre-mRNA
splicing and are predicted to cause in-frame deletions.
Here we report a third distinct disorder, autosomal-
recessive bestrophinopathy (ARB), due to BEST1mutation.
We characterize the detailed clinical features of 5 families,
determine mutations in each of the alleles and show
segregation as a recessive disorder. We conduct whole-cell
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tomeasure the Cl current and show a physiological differ-
ence between ARB alleles and two others associated previ-
ously with Best disease. We subsequently propose that ARB
represents the human null phenotype of bestrophin-1.
Material and Methods
Patient Details
The study was approved by Research Ethics Committees at Moor-
ﬁelds, Manchester Eye, and Ghent University Hospitals. Informed
consent was obtained from all participants prior to conducting
investigations. Clinical examination of members of the affected
families included Snellen visual acuity testing, slit lamp bio-
microscopy, fundoscopy, ISCEV-standard full-ﬁeld electroretino-
gram (ERG), pattern ERG (PERG) and EOG,17–19 and infrared, auto-
ﬂuorescence, and red free imaging. Blood was taken from all
family members by venesection, and genomic DNA was extracted
according to standard procedures.
DNA Sequencing
The exonic regions of BEST1were analyzed by sequencing in fam-
ilies 1–5. The absence of any disease causing mutations for the
three novel mutations p.P152A, p.R200X, and p.V317M in 210
control chromosomes was conﬁrmed by SSCP analysis or restric-
tion digest. For SSCP/heteroduplex analysis (p.V317M), 5 ml PCR
product wasmixedwith 5 ml of formamide loading dye, denatured,
and separated on an 8% acrylamide/bis-acrylamide gel (350 V for
16 hr at 4C) and silver stained in accordance with standard
methods. Restriction digests for the presence of an additional
Cac8I site in a 156 bp amplicon (p.P152A) or absence of a TaqI
site in a 250 bp amplicon (p.R200X) were carried out according
to the manufacturer’s instructions.
Primers were designed to amplify all BEST1 coding exons includ-
ing 50–100 bp of ﬂanking intron sequence (obtained from the
UCSC Genome Browser; primers available on request). PCR reac-
tions with Abgene Reddymix Taq (Abgene, Epsom, UK) contained
50ng genomicDNA in a volumeof 30ml andwere cycled as follows:
95C for 5 min and then 30 cycles of 94C for 30 s; ‘‘x’’ C for 30 s;
72C for 1 min (for which x C is primer annealing temperature)
with a ﬁnal extension of 72C for 10min. PCR products were puri-
ﬁed withMicrocon columns (Millipore, Watford, UK) according to
the manufacturer’s instructions. Standard cycle-sequencing reac-
tions with BigDye terminator mix v1.1 (Applied Biosystems, War-
rington, UK) contained 3–10 ng puriﬁed PCR product in 10 ml
and were performed with forward and reverse primers used for ini-
tial ampliﬁcation. The sequencing reactions were precipitated,
dried, and analyzed on an ABI 3700 capillary sequencer.
Cloning
The wild-type BEST1, p.W93C, and p.R218C cDNA clones in
pADlox3 were a kind gift from Prof A Marmorstein (University of
Arizona). The wild-type clone was used for generating the
p.R141H and p.P152A mutants with the QuickChange II site-
directed mutagenesis kit (Stratagene, Amsterdam, Netherlands)
per the manufacturer’s protocol.
In Vitro Electrophysiology
HEK293 Cell Culture
HEK293 cells were grown inminimum essential mediumwith Ear-
le’s salts and L-glutamine (Invitrogen, Paisley, UK), containing 9%20 The American Journal of Human Genetics 82, 19–31, January 200(v/v) fetal-calf serum (Globepharm, Guildford, UK), 1% (v/v) non-
essential amino acids, gentamicin (0.25 mg/ml), penicillin G (100
U/ml), streptomycin (100 mg/ml), and amphotericin (0.25 mg/ml
(all Invitrogen) at 37C in a humidiﬁed atmosphere of air:CO2
(19:1).
Transient-Transfection Studies
In studies examining bestrophin-1 Cl-channel function, HEK293
cells were transiently transfected with pADlox containing
p.W93C, p.R218C (both Best disease mutations), p.R141H,
p.P152A (both ARB mutations), or wild-type BEST1. Cells were co-
transfected at a 5:1 ratio with the empty vector, pEGFP-C1, as pre-
viously described.20 Positively transfected cells were visualized by
GFP ﬂuorescence, and recordings made only from these cells. We
performed in vitro assay for each vector to show that each was
transcribed to the same level. Recordings of voltage-gated calcium
currents (CaV) were made in HEK293 cells stably expressing L type
a1C subunits.
21 Cells were transiently cotransfected with an auxil-
iary b2a subunit linked to the red ﬂuorescent protein (RFP) and
either wild-type BEST1 or the p.R141H mutant, as previously de-
scribed.20 Cells were transfected in a 5:1 ratio (BEST1:RFP-b2a),
and determination of successful cotransfection was made by visu-
alization of RFP. The b2a subunit was a kind gift from Dr. E. Perez-
Reyes (University of Virginia). The RFPb2a construct and the a1C
cell line were created by Mr. S. Brown (McMaster University).
Whole-Cell Patch Clamp
Patch pipettes were borosilicate capillary tubes (WPI) and were
pulled on a two-stage vertical puller (PC10, Narishige) and ﬁre
polished with tip resistances between 2–4 MU. Conventional
whole-cell recordings were made after establishment of giga-
ohm seals and measured with a Multiclamp 700B ampliﬁer
(Axon) in the voltage clamp mode. Voltage protocols were
driven from an IBM-compatible computer equipped with a Dig-
idata interface (Axon) with pClamp 9 software (Axon).
In experiments that would determine Cl-selective currents, the
extracellular bath solution contained 140 mMNaCl, 2 mM CaCl2,
1 mM MgCl2, 10 mM glucose, 30 mM mannitol, and 10 mM
HEPES, and pH was 7.4 with NaOH. The pipette solution was a
low Cl, high Ca2þ solution containing 20 mM CsCl, 110 mM
Cs aspartate, 2 mM MgCl2, 10 mM glucose, 10 mM HEPES,
10 mM EGTA, and 7.2 mM CaCl2 and pH was adjusted to 7.2
with CsOH. Free Ca2þ concentration was calculated to be approx-
imately 0.5 mM with the WEBMAXC program. Csþ-containing/
Kþ-free solutions eliminated any potential contamination of the
whole-cell currents by endogenous Kþ channels. Asymmetrical
Cl concentrations were used (bath ¼ 146 mM; pipette ¼ 38.4
mM) to help distinguish anion currents (which should reverse
toward ECl ¼ 34 mV) from leak and nonspeciﬁc cation currents
that should reverse at 0 mV. Voltage was stepped from a holding
potential of 50 mV to between 120 to þ80 mV in þ20 mV
steps, and each step duration was 450 ms. Whole-cell capacitance
was compensated with the analog circuitry of the Multiclamp
ampliﬁer.
In experiments that would determine the effects of bestro-
phin-1 on CaV function, 20 mM Ba2þ was used as charge car-
rier (for solution composition, see Hudasek et al.21). Cells were
voltage clamped at 80 mV, and currents were evoked by step-
depolarizing cells to þ10 mV for 100 ms. Currents were ﬁltered
at 5 kHz and sampled at 10 kHz. Activating sections of current
records were ﬁt with a double exponential function of the
form:
I ¼ A23 expðtKÞ=t2 þ A13 expðtKÞ=t1 þ C8
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1able 1. Clinical Details of Affected Individuals from Five Families with ARB
amily
dividual
Age of Visual
Deterioration VA (Snellen) / Refraction
Angle
Closure
Glaucoma Retina
Fluorescein
Angiography ERG
.1 (male) 30 years OD 20/60 þ4/þ1.75 @ 95
OS 20/200 þ4/þ1.5 @ 90
no irregular pale reflex from RPE,
peripheral sparing; small pale
subretinal deposits
early patchy
hyperfluorescence
und
redu
full
.2 (female) 18 years OD hand movement
þ1.75/þ1.0 @ 110
OS 20/120 þ2.25/þ0.75 @ 110
yes bilateral widespread RPE
irregularity with small subretinal
deposits at the posterior poles
widespread early
patchy
hyperfluorescence
redu
full
.1 (female) 40 years OD 20/80 þ0.5DS
OS 20/120 þ1.0/þ1.75 @ 30
no widespread irregularity of the RPE
pigmentation, subretinal deposits
at the maculae with presumed
bilateral macular edema
patchy choroidal
fluorescence
pat
mild
con
dela
.1 (female) 7 years OD 20/80 þ1.25DS/1 @ 40
OS 20/120 þ1.25DS/0.75@ 130
no widespread RPE irregularities
and subretinal deposits
not done pat
mild
con
dela
.1 (female) 4 years OD 20/120 þ4/þ0.5 @ 80
OS 20/200 þ3/þ0.5 @ 120
no scars at each macula and
widespread RPE irregularity
patchy
hyperfluorescence
pat
und
redu
rod
amp
and
.1 (male) 31 years OS 20/60 þ0.5/0.5 @ 90
OS 20/60 þ0.5/0.5 @ 90
yes macular edema, perifoveal
yellow-white deposits;
multiple small white dots
in periphery
early patchy
hyperfluorescence
rod
ERG
.2 (female) 28 years OD/OS 20/20 at presentation yes bilateral macular edema with
white subretinal deposits
in the midperiphery
early patchy
hyperfluorescence
seve
ERG
full
D, right eye; OS, left eye.
in which A1 and A2 are the amplitudes of the fast and slow com-
ponents of channel activation, respectively, t2 and t1 are the time
constants of these components, K is the time at the start of the ﬁt,
and C is the offset.
Results are presented as mean 5 SEM. Data were analyzed by
ANOVA and Student’s t test where appropriate.
Results
Clinical Findings and Molecular Data
Seven affected individuals from ﬁve unrelated families of
European ethnicity were examined. The individual clinical
details are summarized in Table 1, and the pedigrees are
shown in Figure 1. Representative images from color pho-
tography, ﬂuorescein angiography, autoﬂuorescence imag-
ing, and OCT imaging are shown in Figure 2. In all affected
individuals, clinical electrophysiology demonstrated ab-
Figure 1. Pedigrees and Mutation
Analysis
(A) Pedigrees from families 1–4. Sequenc-
ing electropherograms showing homozy-
gous c.598c > t p.R200X variant (top)
and normal sequence (underneath) are
shown to the right of family 1. Electrophe-
rograms from the family 4 patient showing
the c.122t > c p.L41P and c.442 g >
a p.R141H variants are shown to the right
of the pedigree for family 4.
(B) Family 5 pedigree. Pathogenic variants
are inherited separately and have no appar-
ent deleterious phenotypic consequences
in the heterozygous state.
normal full-ﬁeld ERGs in addition to
a severe reduction in the EOG light
rise analogous to that seen with dom-
inant BEST1 mutations that cause
both Best disease and ADVIRC (see
Figures 3 and 4). Sequencing of the
coding fragments of BEST1 identiﬁed
pathogenic sequence variants in all
cases (Figure 1).
From the ﬁve families, 5/7 affected
individuals were female and the age
range at examination was from 28 to
51 years. Six of the individuals pre-
sented with symptomatic central vi-
sual loss (range 4–40 years), whereas
a younger sibling of an affected
brother presented before the onset
of symptoms (patient 5.2, Table 1).
Some older patients (2.1, 3.1) sug-
gested that their central vision had re-
mained stable in recent years. All, on
whom refraction was available, were
hyperopic, and three individuals from two families re-
quired surgery for acute angle-closure glaucoma.
The retinopathy was present in all seven cases and in-
cluded an irregularity of the RPE throughout the posterior
fundus, often with scattered punctate ﬂecks. This was
most easily seen during autoﬂuorescence imaging, which
showed a widespread variability of autoﬂuorescence. Reti-
nal edema and subretinal ﬂuid was common and was con-
ﬁrmed on OCT imaging. No patients were ever noted to
have vitelliform lesions during the course of their follow-
up. Fluorescein angiography showed widespread patchy
hyperﬂuorescence, and EOG consistently showed an
absent or severely reduced light rise. All seven affected
individuals showed signiﬁcant reduction in the PERG (sub-
served by macular function) and reduction and delay of
the rod and cone ERGs (Figure 3).
None of the families had other affected family members.
Ten heterozygotes were examined in detail, and all were22 The American Journal of Human Genetics 82, 19–31, January 2008
Figure 2. Clinical Features of Auto-
somal-Recessive Bestrophinopathy
(A–P) Clinical features of normal controls
and the five ARB families.
(A) Normal fundus of right eye (RE) of
26-year old woman.
(B) Normal autofluorescence of left eye
(LE) of 43-year old man.
(C and D) Fundus picture (C) and autofluo-
rescence (AF) image (D) of LE of proband of
family 1. Note presence of diffuse alter-
ations of RPE and white subretinal deposits
in macular area and midperiphery; changes
are better visible on AF imaging as areas of
hypoautofluorescence and hyperautofluo-
rescence.
(E and F) Fundus picture (E) and AF (F) of
LE of proband of family 2. Retinal pheno-
type is similar to that in (C) with white
subretinal deposits alternating with areas
of RPE atrophy (dark areas on AF).
(G and H) Fundus picture (G) and AF (H) of
RE of proband of family 3, showing wide-
spread RPE irregularities with white sub-
retinal deposits, some of which are better
seen on AF.
(I and J) Fundus picture (I) and AF (J) of
RE of proband of family 4, with central
macular scar visible on fundus picture and
white deposits better seen on AF.
(K–M) Proband of family 5. (K) shows the
composite of fundus of RE with fine white
subretinal deposits surrounding area of
neurosensory detachment in the macula;
additional deposits are visible in retinal
midperiphery and far periphery; (L) shows
optical coherence tomography (horizontal
line scan OCT) of RE showing subretinal
fluid between RPE and neurosensory retina;
and (M) shows slit-lamp image of ex-
tremely shallow anterior chamber of tem-
poral part of LE.
(N–P) Affected sister of proband of family
5. (N) shows the composite AF of LE show-
ing similar, albeit milder, phenotype than
that of her brother; in (O), early-stage
fluorescein angiography of RE shows imme-
diate hyperfluorescence in central macula
probably due to RPE atrophy and retinal
edema; and (P) shows the composite of
fundus of LE.asymptomatic, with a normal retinal examination, ERG
responses, and EOG light rise. These individuals were
heterozygous for the following alleles: p.R200X (aged
68 years), p.R141H (aged 55 years), p.L41P (aged 55 years),
p.M325T (three individuals, aged 16–78 years), and
p.D312N (four individuals, aged 16–73 years).ThGoldmann-Favre syndrome had previously been diag-
nosed in families 1 and 5, and fundus ﬂavimaculatus had
initially been diagnosed in family 3. As part of their clinical
workup, families 3 and 5 had molecular analysis of the
ABCA4 gene performed. No disease-associated variants
were detected in either family.e American Journal of Human Genetics 82, 19–31, January 2008 23
Figure 3. ERG Findings of Autosomal-Recessive Bestrophinopathy
Findings are based on ISCEV (the International Society for Clinical Electrophysiology of Vision) standard. Data from the right eye of four
affected patients (A, B, C, and E) and a representative normal control (D) are shown. BWF represents ISCEV standard flash þ0.6 log units
(better to reveal rod-photoreceptor function, ~11.5 cd.s/m2); in (A), patient II-1, family 1, shows a similar degree of rod-system dys-
function to patient II-1, family 2, but a greater cone-system dysfunction with lower amplitude and increased implicit time. The almost
undetectable PERG is in keeping with severe macular dysfunction. In (B), patient II-1, family 2, shows generalized rod- and cone-system
dysfunction with all ERGs being subnormal and delayed. In (C), patient II-3, family 3, shows a subnormal rod-specific ERG, a mildly sub-
normal BWF ERG a-wave, a borderline subnormal 30 Hz flicker ERG, a photopic ERG within the normal range, and a markedly subnormal
PERG. EOGs in all patients (data not shown) contained either a severely reduced or an undetectable light rise. (E) shows ERG (RE) on an
unaffected 50-year-old female (I-2, family 4) heterozygous for the p.L41P mutation. Note the normal ERG amplitude and 30 Hz flicker
response delay. EOG light rise was 250%.Molecular analysis revealed that all ten BEST1 alleles
were variant (Table 1) encoding six missense (c.122t>c
p.L41P, c.442g>a p.R141H, c.454c>g p.P152A, c.934g>a
p.D312N, c.949g>a p.V317M, and c.974t>c p.M325T)
and one nonsense (c.598c > t p.R200X) mutation. These
were in trans in each affected individual (unable to test
in family 2) and segregated with disease in the two sets
of affected siblings (families 1 and 5).
All novel BEST1 variants were absent from 210 control
chromosomes derived from subjects of European descent.
A ClustalW analysis of the bestrophin-1 protein shows
complete conservation of two regions that harbor 5/6
of the missense variants (p.R141H, p.P152A, p.D312N,24 The American Journal of Human Genetics 82, 19–31, January 200p.V317M, and p.M325T), suggesting they have a critical
functional role within these regions. The sixth sequence
variant (p.L41P) lies outside these regions in an area of
decreased conservation (Figure 5). It is of note that 3/6
missense alterations described in these ﬁve families are
present between residues 312 and 325. These are more
C-terminal than the majority of known mutations in
bestrophin-1, and this ﬁnding suggests that they might
lie in a domain with a distinct function. The residues
in this region are also highly conserved through evolu-
tion and between different members of the bestrophin-1
family of proteins, further suggesting a critical functional
role.8
Figure 4. Longitudinal ERG Findings of Autosomal-Recessive Bestrophinopathy
(A and B) Data from one patient (II-1, family 4), showing deterioration over a 5 year period. Initial findings show mildly subnormal
rod-system ERGs with more marked cone-system abnormalities (reduced and delayed). All full-field ERGs show amplitude reduction
and implicit time increase over a 5 year period, except the single-flash photopic ERG that only shows implicit time increase. The undetect-
able PERG is in keeping with severe macular dysfunction.
(C) Representative normal control. ERGs were recorded in accordance with the recommendations of ISCEV. The rod-specific ERG arises in
the rod ON bipolar cells and acts as a measure of rod-system sensitivity. The BWF ERG has an initial a-wave predominantly arising in
relation to photoreceptor function. This response is dominated by the rod system, but there is a small cone contribution. The 30 Hz flicker
ERG (recorded with a photopic rod-suppressing background) is a cone-system response arising in inner retina and is the most sensitive
measure of generalized cone dysfunction. The single-flash cone has a photopic a-wave to which there is some contribution from the cone
photoreceptors (also the OFF bipolar cells). The PERG P50 component acts as a measure of macular function.Whole-Cell Patch-Clamp Analysis of ARB Mutant
Isoforms
All Best-disease-causing mutations reported to date have
been autosomal dominant, although with varying pene-
trance.22,23 However, the mutations reported here were
found to be inherited in a nondominant manner, and we
investigated the characteristics of two by using whole-cell
patch-clamp methods including the p.R141H mutation
that had been found to be associated with ARB on two sep-
arate occasions. Currents were recorded from HEK293 cells
transfected with wild-type bestrophin-1 (Figure 6B) or with
the p.R141H mutant (Figure 6C). Large currents were ob-
served with the wild-type channel, particularly at positive
(depolarising) potentials, compared to the currents ob-
served in the untransfected HEK293 cells (Figure 6A). The
plot of current as function of voltage for the wild-type
channel (Figure 6D) is similar to that previously reported
for bestrophin-14 and gives a reversal potential of 17.7 5
1.7 mV (n ¼ 16). This is toward the expected value for an
anion-selective current (ECl ¼ 34 mV with 38.4 mM
and 146 mM Cl in the pipette and bath solutions, respec-
tively). This reversal potential indicates that the currents
carried by bestrophin-1 are predominantly anion selective
and are not due to the activation of nonselective cation
channels or an increase in leak current in the transfectedThcells. Assuming that the channels are impermeant to
cations, a value for the relative permeability to the two
anions present (Cl and aspartate) can be calculated,
Paspartate: PCl ¼ 0.31. A similar value has been quoted for
many other anion-selective channels including other
bestrophin channels.13
The currents observed in the cells transfected with the
p.R141H mutant were much smaller than the wild-type
currents (Figures 6C and 6D). The reversal potential
(17.85 3.3 mV, n ¼ 15), however, was not signiﬁcantly
different from that of the wild-type channel (p > 0.1 by
unpaired t test). These data indicate that both wild-type
bestrophin-1 and the p.R141H mutant function as anion-
selective channels in HEK293 cells but that the size of
the whole-cell conductance is signiﬁcantly reduced with
the p.R141H compared to the wild-type channel (p <
0.01; Figure 7C).
To investigate the apparent autosomal-recessive nature
of the p.R141H mutant, we cotransfected it with wild-
type bestrophin-1 into HEK293 cells and examined the
effect on Cl-channel activity. Figure 7A shows typical cur-
rents measured in these experiments. The currents were
similar to those observed with the wild-type channel
alone. The reversal potential also indicated that cotrans-
fection generated a predominantly Cl-selective currente American Journal of Human Genetics 82, 19–31, January 2008 25
Figure 5. Multiple Alignment of Bestrophin-1 around the Mutated Bestrophin-1 Residues Associated with ARB
Multiple alignment (ClustalW) of bestrophin-1 around the mutated residues (p.L41P, p.R141H, p.P152A, p.D312N, p.V317M, and
p.M325T) associated with ARB for nine species (Xenopus tropicalis, Gallus gallus, Tetraodon nigroviridis, Takifugu rubripes, Danio rerio,
Pan troglodytes, Homo sapiens, Canis familiarise, and Rattus norvegicus). The boxes represent transmembrane (TM) domains in the model
proposed by Milenkovic et al.14 Solid lines represent membrane-embedded TM domains, and dashed lines represent ‘‘TM’’ domains outside
the membrane.(16.35 2.6 mV). The magnitude of the mean whole-cell
conductance from 20 recordings was not signiﬁcantly dif-
ferent from that observed with the wild-type channel
alone (p > 0.1 by ANOVA, Figure 7C). Similar results
were obtained with another ARB mutation p.P152A.
Much reduced currents were observed in cells transfected
only with this mutant (n ¼ 10; p < 0.05 compared to26 The American Journal of Human Genetics 82, 19–31, January 200wild-type; Figure 7C). In cells cotransfected with wild-
type and p.P152A, however, the conductances of the cur-
rents observed were not signiﬁcantly different from that
of the wild-type currents (n ¼ 14; p > 0.1; Figure 7C).
In order to establish whether the effects of cotransfection
ofmutant andwild-type bestrophin-1were restricted toARB
mutations, we also performed cotransfection experimentsFigure 6. Whole-Cell Currents from
Normal HEK293 Cells Transiently Trans-
fected with Wild-Type Bestrophin-1
and p.R141H Bestrophin-1 cDNA
Representative traces of HEK293 cells tran-
siently transfected with the following:
(A) EGFP cDNA alone or plus (B) wild-type
bestrophin-1 or (C) p.R141H bestrophin-1
cDNA. Voltage was stepped from a holding
potential of 50 mV to between 120 and
þ80 mV in þ20 mV steps. Step duration
was 450 ms. (D) shows the mean steady-
state current-voltage relationship for mock
transfected HEK293 cells (n ¼ 9) and cells
transfected with wild-type bestrophin-1
(n ¼ 16) or p.R141H bestrophin-1 (n ¼
15). Results are presented as mean5 SEM.8
Figure 7. Cotransfection of Normal
HEK293 Cells with Wild-Type Bestro-
phin-1 plus Either ARB or Best Disease
Mutations Produces Markedly Different
Current Phenotypes
Representative traces of HEK293 cells tran-
siently transfected with wild-type bestro-
phin-1 plus either (A) p.R141H or (B)
p.W93C bestrophin-1. The voltage protocol
was as in Figure 6A. (C) shows themean out-
ward chord conductance (Gchord) in trans-
fected HEK293 cells, calculated over 0 mV
to þ80 mV. *p < 0.05 compared to wild-
type. Results are presented asmean5 SEM.with wild-type bestrophin-1 and two Best-disease-causing
mutants, p.W93C and p.R218C. Currents in cells cotrans-
fected with the wild-type and pW93C mutant were similar
to those observed in untransfected cells (Figure 7B). Figure
7C shows that the mean conductance measured (n ¼ 16)
was not signiﬁcantly different from that in untransfected
cells (p > 0.1) and was signiﬁcantly less than that observed
in cells transfected with wild-type bestrophin-1 alone. Sim-
ilar results were obtained with p.R218C (n¼ 14, Figure 7C).
Bestrophin-1 has previously been reported to modulate
the activation kinetics of a1D subunits of the L type, volt-
age-gated Ca2þ channel (CaV) expressed in RPE cells.7,24 To
investigate whether these data represent a general effect of
bestrophin-1 on CaV channels or is speciﬁc to the CaV a1D,
we performed experiments to investigate the actions of be-
strophin-1 in HEK293 cells stably expressing L type CaV
a1C channel subunits. Figure 8 shows data from these cells
when they are transiently transfected with the CaV auxil-
iary b2A subunit (required for normal CaV activity) and ei-
ther wild-type bestrophin-1 or p.R141H. Figure 8A shows
CaVactivation when themembrane potential was depolar-
ized from 80 to þ10 mV, in cells transfected with CaV
in the absence (solid line) and presence (dotted line) of
wild-type bestrophin-1. The rate of CaV activation was
accelerated in the presence of bestrophin-1. To quantify
this effect, we ﬁtted channel activation with a double
exponential function. Figure 8C shows that wild-type
bestrophin-1 signiﬁcantly reduced the slow rate constant
for activation (p < 0.05), and although the fast rate con-
stant was also reduced, this effect was not statistically
signiﬁcant (p > 0.05). By contrast, coexpression of the
p.R141H mutant had no detectable effect on the rate of
CaV activation (Figures 8B and 8C; p > 0.05 compared to
currents recorded in the absence of bestrophin-1).
Discussion
Until now sequence alterations in BEST1 have been
associated with two distinct autosomal-dominant ocularThphenotypes, Best macular dystrophy and ADVIRC. Here,
we demonstrate that homozygous or compound hetero-
zygous sequence variants in BEST1 also cause a third reti-
nal phenotype that we have termed autosomal-recessive
bestrophinopathy (ARB).
ARB, a Novel Retinal Phenotype Caused by
Compound Heterozygous or Homozygous
BEST1 Mutation
The ARB phenotype is distinct from that seen in Best dis-
ease. None of the patients showed the vitelliform lesions
characteristic of Best disease25 at any time during their fol-
low-up, and none of the ﬁve families had a family history
suggestive of dominant disease. Instead, patients showed
a diffuse irregularity of the reﬂex from the RPE, including
dispersed punctate ﬂecks, which are distinct from the ex-
tramacular vitelliform lesions that have been described in
some cases of Best disease. This was most clearly demon-
strated by autoﬂuorescent imaging (Figure 1). All patients
showed an accumulation of ﬂuid within and/or beneath
the neurosensory retina in the macular region, and such
an accumulation was most likely to be caused the re-
duction of visual acuity. All patients were hyperopic, and
three (from two families) also had angle-closure glaucoma.
In all patients there was a severe reduction in the EOG
light rise similar to that seen in both Best disease and
ADVIRC.
Uniquely, full-ﬁeld ERGs were reduced and delayed for
both cone and rod responses (Figure 3) relatively early in
the evolution of the disease phenotype and, at least in one
case, showed some reduction with time (Figure 4). The ab-
sent or severely reduced light rise on the EOG is not ex-
plained by the magnitude of the ERG abnormalities and
thus conﬁrms a generalized RPE dysfunction. In most
photoreceptor dystrophies, such as the various forms of
retinitis pigmentosa and related disorders, the degree of
EOG light-rise reduction approximates to the degree of rod-
photoreceptor dysfunction demonstrated by ERG. Hence,
a disproportionate EOG reduction might be used to directe American Journal of Human Genetics 82, 19–31, January 2008 27
mutational screening of BEST1 in Best disease, ADVIRC,
and ARB.
Electrophysiology is crucial to diagnosis. Ten proven
heterozygous carriers from four families including parents
(n ¼ 4), an uncle, an unaffected sibling, and children
(n ¼ 4) were examined clinically and tested with ERG
and EOG. None of these individuals had symptoms of
retinal disease, and all had normal cone and rod ERG re-
sponses and a normal EOG light rise. This strongly suggests
that heterozygosity for alleles causative of ARB does not
cause clinical or subclinical human disease in the majority
of cases. This differs from the report of Shatz et al.15 who
Figure 8. Ca2þ-Channel Activation Is Accelerated by Wild-
Type Bestrophin-1, but Not the p.R141H Mutant
Recordings were made in HEK293 cells stably expressing L type cal-
cium channel a1C subunits.
21 Cells were also transiently transfected
with an RFP-b2a construct, which also acted as an expression
marker. (A) shows representative traces taken from cells expressing
CaV channels alone (unbroken line) and coexpressing wild-type be-
strophin-1 (dashed line). Currents were evoked by step-depolariz-
ing cells þ10 mV from a holding potential of 80 mV. Currents
have been scaled such that peak current amplitudes are the same
in each case. (B) is as shown in (A), except cells coexpressed the
p.R141H bestrophin-1 mutant. (C) shows the mean time constants
for channel activation, derived from recordings such as those in (A)
and (B). Activating sections of current traces were fit with a double
exponential function, yielding time constants (t) for the fast and
slow components of channel activation. Data are means (5SEM)
taken from eight or nine cells in each case. NS, not significant.
*p < 0.05.28 The American Journal of Human Genetics 82, 19–31, January 200have described an ‘‘atypical’’ form of Best disease associ-
ated with compound heterozygous mutations (p.R141H
and p.Y29X), in which one 59-year-old heterozygote had
a reduction of ERG amplitudes, but a normal EOG light
rise. Although the ERGs are difﬁcult to compare with our
own (because of the different standards used), it might be
signiﬁcant that this individual had a normal EOG light ri-
se, a response that is the most sensitive test for bestrophi-
nopathies. Our data suggest that this ‘‘atypical’’ form of
Best disease is likely to be ARB.15
We sequenced BEST1 in ﬁve ARB families, identifying
seven homozygous or compound heterozygous variants.
Six were missense variants, and there was a one nonsense
alteration. All novel variants were absent from 210 control
chromosomes and were in conserved residues. Therefore,
the large majority of BEST1 mutations that cause Best dis-
ease, ADVIRC, and ARB are missense (Figure 9). However,
the identiﬁcation of the p.R141H and p.L41P variants in
two families suggests a correlation between genotype
and phenotype. It might also be functionally signiﬁcant
that 3/6 missense alterations (p.D312N, p.V317M, and
p.M325T) are located closer to the C terminus than previ-
ously described missense mutations. The region is con-
served within the family of bestrophins and suggests it
might have a critical functional role. The C-terminal re-
gion of bestrophin-1 interacts with protein phophata-
se2A,26 and it might be that these residues are important
in this regulatory interaction.
Cellular Electrophysiological Properties of Mutant
Bestrophin-1 Variants that Cause ARB
Previous studies have investigated the cellular electrophys-
iological properties of dominant mutant bestrophin-1 iso-
forms. In one, transient transfection of missense isoforms
resulted in normal targeting to the cell membrane but
an abolition of Cl current. Additionally, the mutant iso-
forms associated normally with wild-type protein and in-
hibited its chloride-channel activity.4,22 We conﬁrmed
this for two Best-disease-associated mutations, p.W93C
and p.R218C (Figure 8). In contrast, we have shown that
the ARB variants p.R141H and p.P152A severely reduce
Cl-channel activity in HEK293 cells (Figure 6) when
expressed alone but do not signiﬁcantly alter the conduc-
tance when coexpressed with wild-type bestrophin-1 (Fig-
ure 8). Therefore, we have demonstrated that channels
containing onlymutant isoforms of bestrophin-1 are likely
to produce little or no activity when present in the homo-
zygous, or presumably compound heterozygous, states
(Figure 8). Because heteromeric mutant wild-type channels
are much less reduced in function, we suggest that carriers
with one wild-type and one mutant allele retain sufﬁcient
channel activity to be phenotypically normal, unlike Best
disease patients who only require the expression of one
mutant allele. In all of our in vitro experiments, we demon-
strated comparable transfection efﬁciencies and demon-
strated that transcription of the constructs was equivalent.8
It will be important to determine therefore whether the
reduced activity associated with ARB mutations is due
to a decrease in the number of membrane channels (for ex-
ample as a result of reduced protein stability or altered
membrane targeting) or to a change in single-channel prop-
erties.
In a separate series of experiments, the expression of
wild-type bestrophin-1 in HEK293 cells expressing the
a1C subunit of CaV was found to modulate the activation
kinetics of the CaV channel (Figure 7). Similar effects have
previously been observed with the a1D subunit in RPE
cells.7 These data suggest that bestrophin-1 might modu-
late the activity of all L-type CaV channels and that the
phenomenon is not conﬁned to RPE cells. Coexpression
studies with the p.R141H channel found no effect on
CaV activity (Figure 7). Similar observations have previ-
ously been made with the p.W93C and p.R218C mutant
isoforms.7 Whether this effect is due to a decrease in the
mutant channel activity, or because of reduced protein-
protein interaction between the mutant bestrophin-1
and CaV subunits, remains to be deﬁned.
Phenotypic heterogeneity associated with recessive
or dominant mutations within the same gene is well recog-
nized.27 Three of the variants we describe have previously
been shown to cause dominantly inherited phenotypes.
Two, p.L41P and p.R141H, have been reported in
Figure 9. Diagram of Bestrophin-1
Summarizing Known Mutations Associ-
ated with Best Disease, Adult Vitelli-
form Macular Degeneration, ADVIRC,
and ARB
Topology is based on that determined by
Milenkovic et al.14
Best disease,9,10,15,28 whereas the
p.D312N variant has been described
in a family with adult vitelliform
macular dystrophy.10 Because full
clinical details were not given, it is
difﬁcult to be certain of the signiﬁ-
cance of these observations, although
it is interesting that all three variants
demonstrated reduced penetrance.
Although incomplete penetrance
(even for electrophysiological abnor-
malities) is well recognized in Best
disease,2,22,23 the clinical picture,
lack of a dominant family history,
and absence of electrophysiological
abnormalities in heterozygous car-
riers lead us to conclude that it is
not incomplete penetrance that we
are observing here. It remains possi-
ble that certain variants that have
pathogenic manifestations in homo-
tzygous or compound heterozygous states might also occa-
sionally be disease causing in the heterozygous state.
ARB Is the Null Human Phenotype of Bestrophin-1
In family 1, we describe a homozygous nonsense alter-
ation, p.R200X. It is likely that this variant (in exon 5 of
an 11 exon gene) undergoes nonsense-mediated decay
(NMD), although it was not possible to prove this in vivo
because of BEST1 expression being restricted to the RPE.
The cellular electrophysiological data and our observation
of a similar phenotype in all ﬁve ARB families suggest that
either homozygosity or compound heterozygosity for the
variants we describe severely reduce bestophin-1 function.
This leads us to conclude that the ARB phenotype repre-
sents the true bestrophin-1 null phenotype in humans. A
recessive Best1 retinopathy in the dog, termed canine mul-
tifocal retinopathy, was recently described. The two re-
ported homozygous alterations (p.R25X and p.G161D)
did not cause a fundus phenotype in obligate heterozy-
gotes, and we think it is likely that these models will be
useful in modeling ARB rather than Best disease, as the
authors suggest.29
This report adds to the spectrum of phenotypes asso-
ciated with BEST1mutations, in which bestrophin-1 chan-
nel activity is a major determinant of phenotype. OurThe American Journal of Human Genetics 82, 19–31, January 2008 29
recognition of the human null phenotype helps in the un-
derstanding of the molecular mechanisms underlying the
pathogenesis of the expanding range of disorders or ‘‘be-
strophinopathies’’ that are caused by BEST1 mutation.
Alongside the identiﬁcation of large-animal models, this
might lead to the development of novel treatment modal-
ities for this important group of disorders.
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